For the Inventor, By the Inventor

Enter assignee name

San Juan Capistrano, CA, United States of America

Celera Corporation

USPTO Granted Patents = 98

CIPO Patents = 16

EPO Patents = 51

Trademarks = 11

Forward Citations = 574

Loading Chart...

Loading Chart...

82 inventors (with patents filed for the assignee):

James J Devlin (23 out of 39 patents)

Steve Ruben (23 out of 23 patents)

Steven Schrodi (14 out of 14 patents)

4. Olga Iakoubova (13 out of 13 patents)

5. Ann Begovich (13 out of 16 patents)

6. Tao He (12 out of 16 patents)

7. Bruno Domon (11 out of 15 patents)

8. Candy Lee (10 out of 10 patents)

9. Karen Mason (9 out of 9 patents)

10. John Mason (9 out of 13 patents)

11. Yonghong Li (9 out of 9 patents)

12. Dov Shiffman (8 out of 12 patents)

13. Michele Cargill (8 out of 9 patents)

14. Charles E Birse (8 out of 11 patents)

15. Calum MacRae (7 out of 7 patents)

Core Competencies:

Automated Circuit Generation

Genetic Polymorphisms

Cardiovascular Diseases

Drug Response

Breast Cancer Metastasis

Lung Cancer Markers

Statin Response

Psoriasis

Rheumatoid Arthritis

Venous Thrombosis

Molecular Prognostic Signature

Alkaline Membrane Fuel Cells

98 patents: Sort by Forward Citations

1. 12141511 - Automated circuit generation (2024-11-12),

2. 12093619 - Automated circuit generation (2024-09-17),

3. 12093618 - Automated circuit generation (2024-09-17),

4. 12079555 - Automated circuit generation (2024-09-03),

5. 12073157 - Automated circuit generation (2024-08-27),

6. 11827937 - Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof (2023-11-28),

7. 11814684 - Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof (2023-11-14),

8. 11802164 - Methods and compositions for diagnosing and treating diseases (2023-10-31),

9. 11788143 - Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof (2023-10-17),

10. 11708610 - Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof (2023-07-25),

11. 11697850 - Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment (2023-07-11),

12. 11694007 - Automated circuit generation (2023-07-04),

13. 11408034 - Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof (2022-08-09),

14. 11401555 - Genetic polymorphisms associated with stroke, methods of detection and uses thereof (2022-08-02),

15. 11361134 - Automated circuit generation (2022-06-14),

Celera Corporation is a biotechnology company focused on developing innovative diagnostic products and services for personalized medicine. With a deep understanding of genomics and molecular diagnostics, Celera has revolutionized the field with advanced technologies and data analysis techniques. By combining cutting-edge research with clinical applications, the company aims to improve patient outcomes and enable targeted therapies. Visit the website to learn more about Celera's pioneering work in genomics and diagnostics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

98 Patents

#1 in San Juan Capistrano, CA

#877 in California

#3,718 in US

#7,695 in the World

San Juan Capistrano, CA, United States of America

Celera Corporation

Forward Citations = 574

82 inventors:

James J Devlin (23 out of 39 patents)

Steve Ruben (23 out of 23 patents)

Steven Schrodi (14 out of 14 patents)

4. Olga Iakoubova (13 out of 13 patents)

5. Ann Begovich (13 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…